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ABSTRACT 
 
 The mould Aspergillus giganteus produces a basic, low molecular weight 
protein (AFP) showing in vitro and in vivo antifungal properties against 
important plant pathogens. AFP is secreted as an inactive precursor containing 
an amino-terminal extension of six amino acids (If-AFP) which is later removed 
to produce the active protein. The molecular basis to explain this behavior and 
the features that determine the fungal specificity of this protein are not 
completely solved. In this work, the mature AFP (AFP*) and a version of AFP 
with an extended amino-terminal (proAFP) have been cloned and produced in 
the yeast Pichia pastoris. The two proteins have been purified to homogeneity 
and characterized from structural and functional points of view. AFP* produced 
is practically indistinguishable from the natural fungal protein in terms of its 
spectroscopic and antifungal properties while proAFP is mostly inactive under 
identical assay conditions. The availability of an active AFP protein produced in 
P. pastoris will allow getting further insights into the mode of action and 
targeting specificity of AFP by using site-directed mutagenesis approaches  
 
Keywords: antifungal, antimicrobial, cysteine-rich, peptide. 
 
Abbreviations used: BMMH, buffered minimal methanol medium supplemented 
with histidine; AFP, antifungal protein from Aspergillus giganteus; AMPs, 
antimicrobial peptides; PDB, potato dextrose broth. 
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Introduction 
 
 Peptides and small proteins exhibiting direct antimicrobial activity have 
been characterized from many organisms throughout all kingdoms [1]. The 
general biological role of antimicrobial peptides and proteins in defense against 
challenging microbes is recognized and they are proposed as promising tools 
for the development of new antifungal therapies in medicine and agriculture [2-
4]. Moreover, the transgenic expression of antimicrobial genes has been 
successfully used to improve resistance to fungal diseases in many plant 
species [5-8]. 
Filamentous fungi themselves can be considered as valuable sources for 
the production of antifungal peptides and proteins [9,10]. One of these 
promising polypeptides is the antifungal protein (AFP) secreted by the mould 
Aspergillus giganteus. AFP is a basic, low molecular weight (51 residues long) 
protein showing in vitro antifungal properties against important plant pathogens, 
including Magnaporthe oryzae, Fusarium verticilloides, Phytophthora infestans, 
and Botrytis cinerea [11-15]. These fungi are responsible for important diseases 
in a large number of plants with agricultural and economical importance, such 
as rice, wheat, potato, or tomato. In addition, transgenic expression of the afp 
gene, either alone or in combination with other antimicrobial genes, has been 
shown to confer disease resistance [6,16-18]. 
AFP has been thoroughly characterized from structural and 
spectroscopic points of view, including the resolution of its three-dimensional 
structure in solution [11,19]. It displays the characteristic features of an 
oligonucleotide/oligosaccharide binding (OB-fold) structural motif [20] being a 
small and compact β-barrel composed of five highly twisted antiparallel β-
strands. It should be also mentioned that cysteine pairing isomerism exists 
within its four disulfide bridges [19]. AFP is secreted as an inactive precursor (lf-
AFP) containing an amino-terminal extension of six amino acids [12]. 
AFP is also a member of an emerging family of small cysteine-rich 
antifungal proteins, secreted by ascomycetes [9]. Other well characterized 
member of the same family is PAF from Penicillium chrysogenum [9]. The 
structure of PAF is coincident in many aspects with that of AFP, including the 
impossibility of unambiguously assigning of the disulfide pattern [21]. Although 
PAF is closely related to AFP from a structural point of view, it shows slightly 
different functionality and antifungal specificity [9]. The paf gene has been 
recently cloned and the PAF polypeptide successfully produced in P. pastoris. 
This has allowed the determination of its three-dimensional structure in solution 
and the production and characterization of several interesting mutants [21]. 
Although an enormous number of peptides and proteins endowed with 
antimicrobial activity are now known, the mechanism by which most of them 
exert their activity has been only partially solved and still remains a matter of 
discussion [reviewed in 22]. Concerning AFP, it has been reported that this 
protein enters the fungal cells by its ability to interact with phospholipid 
membranes [11] thus causing membrane permeabilization in the target fungal 
cell [15,23]. In other studies, it was reported that AFP binds fungal cell wall 
chitin [24]. Apparently, the AFP protein enters into the fungal cell and targets 
the nucleus, as revealed by co-localization experiments of Alexa-labeled AFP 
with the SYTOX Green dye [15]. AFP would bind fungal nucleic acids promoting 
charge neutralization and condensation of DNA [15,20], maybe triggering 
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apoptosis [23]. The available data suggest that it is this combination of fungal 
cell permeabilization, cell-penetrating ability and nucleic acid-binding activity of 
AFP that determines its potent antifungal activity. Unfortunately, the molecular 
basis for this behavior and, more important, the features that determine the 
fungal specificity of the protein are still far from solved. As stated above, the fact 
that PAF displays different specificity and presumably different cytotoxic 
mechanism [9] does not help us to reach a consensus on the mode of action of 
this family of antifungal proteins. 
In order to further explore the molecular details by which AFP exerts its 
antifungal activity, both the mature protein and a version with an extended 
amino-terminal have been cloned and produced in the yeast P. pastoris. Both 
proteins have been purified to homogeneity and characterized from structural 
and functional points of view. 
 
 
 
Materials and Methods 
 
 
Cloning procedures 
 
The Aspergillus cDNA sequence encoding the mature AFP protein (51 
amino acids and the stop codon) was amplified by PCR using the pBSK(-)afp 
plasmid as template [17]. Two different afp plasmid constructs in which the 
mature AFP protein was translationally fused to the yeast α-factor signal 
sequence for secretion were prepared. The first construct contained the afp 
cDNA fused to the complete yeast α-factor signal peptide sequence (plasmid 
pPICZαproAFP). To obtain this plasmid, the afp cDNA was PCR amplified using 
the following primers: 5’GAATTCGCCACATACAATGGCAAA3’ (N-terminal-A 
primer) and 5’TCTAGACTAGCAGTAGCACTTCCCC3’ (C-terminal primer). 
During the PCR reaction, EcoRI and XbaI sites were introduced into the PCR 
amplified DNA fragment (underlined nucleotides in PCR primer sequences). 
Next, the afp cDNA sequence was inserted into the EcoRI and XbaI digested 
pPICZαA plasmid for expression in P. pastoris. In this way, the AFP cDNA was 
inserted in frame with the complete yeast α-factor signal sequence, including 
the Kex2 and Ste13 signal cleavage sites (Fig. 1). 
A second construct was prepared in which the mature AFP was fused to 
a mutated version of the yeast α-factor sequence in which a deletion was 
introduced to remove the Ste13 cleavage sites (plasmid pPICZαAFP). For this, 
the oligonucleotide  
5’GGGGTATCTCTCGAGAAAAGAGCCACATACAATGGCAAA3’ (N-terminal-B 
primer) and the C-terminal primers were used. A XhoI restriction site was 
introduced at the N-terminal-B oligonucleotide primer suitable for the 
subsequent cloning steps (underlined nucleotides). Constructs, pPICZαproAFP 
(containing the full α-factor signal peptide sequence) and pPICZαAFP (the 
plasmid where the Ste13 signal cleavage sites had been removed) were verified 
by nucleotide sequencing (DNA sequence facility from the Universidad 
Complutense). 
 
Protein production and purification. 
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In order to produce the recombinant version of AFP in P. pastoris, 
plasmids (1 µg) pPICZαproAFP and pPICZαAFP were digested with Sac I and 
used to transform KM71 cells by electroporation on a Bio-Rad Gene-Pulser 
apparatus as described [25]. The pPICZαA plasmid contains the gene that 
confers resistance to the antibiotic zeocin. Thus, after the pulse cells were 
immediately diluted with 1 ml of cold 1 M sorbitol and plated on YPD (1% yeast 
extract, 2% peptone and 2% dextrose) medium containing 1 M sorbitol and 
different amounts of zeocin (100-1500 µg/ml). Incubation at 30ºC was 
performed until colonies appeared (4 days). In each case, the best producing 
colony was selected, among 10 tested, by small scale production experiments 
and SDS-PAGE analysis of the extracellular media at different times of culture. 
The selected colonies were used for large-scale production of recombinant AFP 
or proAFP in 200 ml of buffered minimal methanol medium supplemented with 
histidine (BMMH) medium. Incubation was carried out at 30ºC for two days with 
strong aeration. Then, the extracellular medium was obtained by centrifugation 
and used to purify the recombinant proteins essentially as described before 
[11,12]. After dialysis of the extracellular medium against 50 mM sodium 
phosphate, pH 7.0, the proteins were retained on a cation exchange column of 
Amberlite IRC 50, equilibrated in the same buffer. After washing the column 
with 0.2 M NaCl, the proteins were eluted with a 0.6 M solution of the same salt. 
Then, the fractions containing the desired proteins were thoroughly dialyzed 
against water and lyophilized. 
Fungal native natural AFP was also produced in A. giganteus MDH18894 
liquid cultures and later purified following a standardized procedure described 
before [11]. 
 
Characterization of the purified proteins. 
 
SDS- PAGE, Western immunoblots, protein hydrolysis and amino acid 
analyses were carried out as previously described [11,12,25-27]. The amino-
terminal sequences were determined by Edman degradation using an Applied 
Biosystems model 477A sequencer. Mass spectrometry analysis was made as 
described before [26,27] on an Autoflex III MALDI-TOF-TOF instrument (Bruker 
Daltonics, Bremen, Germany) with a smartbeam laser. Both types of 
determinations, protein sequencing and mass spectrometry, were performed at 
the C.I.B.-C.S.I.C. (Madrid, Spain) Proteomics and Genomics facility. 
Absorbance measurements were performed on an Uvikon 930 
spectrophotometer at 100 nm/min scanning speed, at room temperature and in 
1 cm optical path cells. Circular dichroism (CD) spectra were obtained on a 
Jasco 715 spectropolarimeter, equipped with a thermostated cell holder and a 
NesLab-111 circulating water bath, at 0.2 nm/s scanning speed. The instrument 
was calibrated with (1)-10-camphorsulfonic acid. CD spectra were recorded in 
cylindrical cells of 0.1 cm optical path. Mean residue weight ellipticities were 
expressed in units of degree x cm2 x dmol-1. All these determinations were 
performed under conditions described elsewhere [11,20,27]. 
 
In vitro antifungal activity of the purified proteins. 
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The fungal rice pathogen F. verticilloides (supplied by the “Servei de 
Protecció Vegetals, Autonomous Government of Catalonia) was routinely 
cultured on potato dextrose agar (PDA) (Difco, Detroit, MI, USA) plates for 12 to 
15 days at 28ºC. Spores were collected with distilled water, filtered and titrated 
with a hemacytometer.  
The in vitro antifungal activity of both P. pastoris-produced recombinant 
AFPs, as well as the A. giganteus-produced natural AFP, was determined using 
a microtiter plate assay as previously described [13,15,28]. Briefly, 90 μl of a 
fungal spore suspension at 105 spores/ml in PDB (potato dextrose broth; 
DIFCO, Detroit, MI, USA), containing 0.003% (wt/vol) chloramphenicol, was 
allowed to pre-germinate for 6 h at 28°C. The purified AFP was added to the 
pre-germinated conidia to reach the desired final concentrations and the 
microtiter plates were incubated at 28°C. The ability of the AFP proteins to 
inhibit fungal growth was determined by measuring optical density at 595 nm 
(OD595) over time in a microplate reader (Synergy 2 Multi-Mode Microplate 
Reader, Biotek Instruments, Inc., VT, USA). In all the experiments made, three 
replicates were prepared for each treatment; the blank mean OD595 value from 
one row of mock inoculations was subtracted from the OD595 measurement of 
each well, and the mean and standard deviations (SD) were then calculated for 
each treatment. 
The fungicidal activity of the P. pastoris produced AFP proteins was also 
assessed and compared with that of the natural active protein. For this, aliquots 
of fungal cultures at each peptide concentration treatment were taken at 1 day 
of incubation, diluted in distilled water, and spread onto peptide-free PDA plates 
to monitor viability.  
 
Results. 
 
Protein purification and characterization. 
 
The homogeneity of the purified recombinant proteins produced by P. 
pastoris cells harboring either the pPICZαproAFP or the pPICZαAFP construct 
was initially assessed by SDS-PAGE. The protein fraction obtained from cells 
transformed with the plasmid pPICZαproAFP contained two immunoreactive 
polypeptides showing a lower mobility compared to that of the natural fungal 
protein (Fig. 2). This result suggested the presence of at least two molecular 
species of AFP-like proteins within this preparation. Mass-spectrometry analysis 
revealed that the two proteins had molecular masses of 6274 and 6474, 
whereas the expected mass for the mature fungal protein was 5798 (in the 
absence of free sulfihydril groups). This finding was consistent with the 
occurrence of partial cleavage at the two Ste13 sites and the formation of all the 
four possible disulfide bonds. Amino-terminal sequence confirmed the presence 
of two different N-terminal sequences resulting from cleavage at the Kex2 and 
the first Ste13 site (Fig. 1). From this, it was concluded that the AFP protein 
produced in P. pastoris by using the pPICZαproAFP contained two protein 
species with an extension of 6 and 4 amino acid residues at the amino terminus 
of the wild-type natural fungal mature AFP (Fig. 1). This protein preparation was 
thereafter designated as proAFP. 
On the other hand, the electrophoretic behavior of the protein purified 
from cells harboring pPICZαAFP was indistinguishable from that displayed by 
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the natural fungal protein (Fig. 2). This protein also reacted with the antiserum 
against the natural protein and its molecular mass was coincident with that 
expected for the mature AFP (5798). Therefore, it was safely assumed that this 
protein corresponded to the fungal mature AFP, including the establishment of 
four disulfides, and was then designated as AFP*. The amino acid composition 
was coincident with that expected according to the characterization explained 
above. Finally, far-UV CD spectra of the two proteins studied, proAFP and 
AFP*, showed the unique shape of these particular polypeptides (Fig. 3). Their 
CD spectra were very similar to those displayed by either the fungal mature 
AFP protein [11] or the inactive precursor of the A. giganteus-produced AFP 
protein [12], indicating the preservation of the global native conformation of the 
recombinant proteins. 
The proAFP and AFP* proteins were purified from P. pastoris with yields 
of about 40.0 and 2.5 mg/L of BMMH producing medium, respectively. 
 
Antifungal activity of the P. pastoris-produced AFP proteins. 
 
The antifungal activity of the two AFPs produced in P. pastoris was 
measured against the fungal pathogen F. verticilloides and compared with the 
activity of the natural AFP produced by A. giganteus. AFP* and natural fungal 
AFP delay or complete inhibit fungal growth, being the natural protein only 
lightly more active than the recombinant one (i.e. 14% and 27% growth at a 
concentration of 0.5 µM for the natural mature AFP and AFP*, respectively (Fig. 
4A). 
The fungicidal activity of natural mature AFP and AFP* was assayed on 
pre-germinated conidia. Similar loss of viability of F. verticilloides spores was 
observed after 24h of incubation with these two AFP proteins (Fig. 4B) (i.e. lost 
of viability spores by approximately 1 log unit with at 2 µM of AFP*, compare to 
lightly more lost of viability with natural mature AFP in identical conditions). 
Finally, the proAFP protein had a low inhibitory activity of fungal growth 
and almost no effect on spore viability at 4 M (Fig. 4). 
 
Discussion. 
 
Developing biotechnological approaches for the production of 
antimicrobial peptides and proteins (AMPs) is of paramount importance to 
ensure efficient and safe applications of AMPs in biomedicine and agriculture. 
In addition to expanding our knowledge on the mode of action of AMPs their 
production might be useful for future use of AMPs as protective agents for plant 
protection, food, veterinary and human pharma sectors. 
Within this idea, two versions of the AFP protein, proAFP and AFP*, have 
been produced in the heterologous system of P. pastoris with yields in the order 
of milligrams. Both recombinant proteins showed spectroscopic properties 
compatible with the assumption of the native fold of the original fungal protein. 
The most prominent feature of the far-UV CD spectrum of AFP is the presence 
of a strong positive band at 230 nm due to its high content of tyrosine residues 
[11]. This band is directly related to the native protein conformation but hampers 
calculations aimed to estimate secondary structure contents. The existence of 
different sets of disulfide bridges patterns within the same protein preparation 
further complicates this interpretation [19,21]. 
8 
 
Purified AFP* displays an antifungal activity comparable to that of the 
Aspergillus produced AFP protein whereas the proAFP protein exhibits low 
antifungal activity under identical assay conditions. This observation suggests 
that the much lower yield of AFP* when compared to the other protein produced 
might be due to this lack of antifungal activity of proAFP. In this respect, it is 
worthwhile to remind that the natural AFP that is produced by A. giganteus is 
secreted to the extracellular medium as an inactive precursor (lf-AFP), 
containing six extra residues at its amino-terminal end. This precursor form is 
further processed by still uncharacterized proteolytic activities of the final 
mature active form [12]. Taking into account that the six (or four) extra residues 
at the amino-terminal end of proAFP are completely different from those 
appearing in the N-terminal of the natural inactive precursor (Table 1), it is 
tempting to speculate that any polypeptide extension at the AFP N-terminal 
would impair the establishment of essential interactions for its antifungal activity. 
The production of active recombinant AFP will allow exploring in more 
detail the mode of action of this protein against target pathogens. Considering 
that AFP* can be easily purified in large amounts from P. pastoris cultures, it 
offers an attractive model for its rapid and convenient production. As an 
example, direct application of AFP can be considered for protection of plants 
against infection by the fungal pathogen F. verticillioides. This fungus not only 
causes important losses in productivity in a large number of cereals and 
grasses but also reduces their quality by producing toxins, namely fumonisins, 
which affect human and animal health [29]. 
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Table 1 
 
Amino-terminal sequences of the natural (lf-AFP) [12] and recombinant 
(proAFP) inactive larger versions of AFP. The residue corresponding to the first 
position of mature AFP appears underlined. 
 
Protein Sequence 
lf-AFP Asp-Glu-Ser-Ala-Val-Leu-Ala-Thr-... 
proAFP Glu-Ala-Glu-Ala-Glu-Phe-Ala-Thr-... 
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Fig. 1. Detail of the sequences existing at the boundary of the α-factor signal 
peptide and the mature form of AFP for the two different plasmids employed. 
(A) pPICZαproAFP and (B) pPICZαAFP. The endonuclease restriction and 
signal peptide cleavage sites are also shown. 
 
Fig. 2. Purity of the P. pastoris produced AFP proteins. SDS-PAGE (A) and 
Western blot (B) analysis of the natural and recombinant versions of AFP: 
fungal wild-type protein (lanes 1), proAFP (lanes 2), and AFP* (lanes 3). MW: 
Precision Plus Protein Standards (BioRad), molecular masses in KDa are 
indicated on the left side of the figure. 
 
Fig. 3. Far-UV circular dichroism spectra of fungal native AFP (black circles) 
and its two recombinant versions: proAFP (white circles) and AFP* (gray 
circles). 
 
Fig. 4. In vitro antifungal activity of natural AFP (black bars), AFP* (gray bars), 
and proAFP (striped bars) against F. verticilloides. (A) Fungal growth is 
expressed as mean values of percentage of the growth of control cultures 
(100% represents fungal growth in PDB medium without AFP) ± SD, at each 
peptide concentration and after 48h of protein-fungi incubation. (B) Fungicidal 
activity is expressed as mean values of viable spores /ml ± SD, at each peptide 
concentration and after 24h of protein-fungi incubation. Dot line represents the 
initial concentration of spores. 
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